Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sumatriptan/Naproxen for Acute Migraine
NCT04948164Phase 3Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Aug 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sumatriptan, Aprol in migraine, sponsored by Peking University Third Hospital. Status: unknown.
02
Drugs
sumatriptanAprol
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04948164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04948164.